Sacubitril/valsartan in real-life clinical practice
Saved in:
Main Author: | Yüksel Çavuşoğlu |
---|---|
Format: | article |
Language: | EN TR |
Published: |
KARE Publishing
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/cf3f1f032c954c9fb59b5b68d0cef516 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tolerability Profile and Discontinuation Causes of Sacubitril/Valsartan Treatment in ‘Real-life’ Patients with Heart Failure and Reduced Ejection Fraction
by: M Rizzo, et al.
Published: (2020) -
Sacubitril/valsartan alleviates myocardial fibrosis in diabetic cardiomyopathy rats
by: Jiao Ai, et al.
Published: (2021) -
Rationale for and Practical Use of Sacubitril/Valsartan in the Patient’s Journey with Heart Failure and Reduced Ejection Fraction
by: Mauro Gori, et al.
Published: (2021) -
Editorial
by: Hakan Alta, et al.
Published: (2021) -
Prescription of Sacubitril/Valsartan in Patients with Heart Failure and Reduced Ejection Fraction Attending an Outpatient Heart Failure Clinic
by: M Rizzo, et al.
Published: (2020)